288 related articles for article (PubMed ID: 16336202)
1. SLPI and elafin: one glove, many fingers.
Williams SE; Brown TI; Roghanian A; Sallenave JM
Clin Sci (Lond); 2006 Jan; 110(1):21-35. PubMed ID: 16336202
[TBL] [Abstract][Full Text] [Related]
2. Human neutrophil elastase inhibitors in innate and adaptive immunity.
Fitch PM; Roghanian A; Howie SE; Sallenave JM
Biochem Soc Trans; 2006 Apr; 34(Pt 2):279-82. PubMed ID: 16545094
[TBL] [Abstract][Full Text] [Related]
3. Innate immune defences in the human uterus during pregnancy.
King AE; Kelly RW; Sallenave JM; Bocking AD; Challis JR
Placenta; 2007; 28(11-12):1099-106. PubMed ID: 17664005
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML
Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
[TBL] [Abstract][Full Text] [Related]
5. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
[TBL] [Abstract][Full Text] [Related]
6. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
7. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of antiproteinases.
Sallenave JM
Biochem Soc Trans; 2002 Apr; 30(2):111-5. PubMed ID: 12023836
[TBL] [Abstract][Full Text] [Related]
9. Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.
Sallenave JM
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):635-43. PubMed ID: 20395631
[TBL] [Abstract][Full Text] [Related]
10. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.
Ashcroft GS; Lei K; Jin W; Longenecker G; Kulkarni AB; Greenwell-Wild T; Hale-Donze H; McGrady G; Song XY; Wahl SM
Nat Med; 2000 Oct; 6(10):1147-53. PubMed ID: 11017147
[TBL] [Abstract][Full Text] [Related]
11. Trappin ovine molecule (TOM), the ovine ortholog of elafin, is an acute phase reactant in the lung.
Brown TI; Mistry R; Collie DD; Tate S; Sallenave JM
Physiol Genomics; 2004 Sep; 19(1):11-21. PubMed ID: 15292488
[TBL] [Abstract][Full Text] [Related]
12. Secretory leukocyte peptidase inhibitor and lung cancer.
Nukiwa T; Suzuki T; Fukuhara T; Kikuchi T
Cancer Sci; 2008 May; 99(5):849-55. PubMed ID: 18380788
[TBL] [Abstract][Full Text] [Related]
13. War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection.
Drannik AG; Henrick BM; Rosenthal KL
Biochem Soc Trans; 2011 Oct; 39(5):1427-32. PubMed ID: 21936827
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells.
Higashimoto Y; Yamagata Y; Iwata T; Ishiguchi T; Okada M; Masuda M; Satoh H; Itoh H
Respiration; 2005; 72(6):629-35. PubMed ID: 16355004
[TBL] [Abstract][Full Text] [Related]
15. In silico study of whey-acidic-protein domain containing oral protease inhibitors.
Idoji Y; Watanabe Y; Yamashita A; Yamanishi K; Nishiguchi S; Shimada K; Yasunaga T; Yamanishi H
Int J Mol Med; 2008 Apr; 21(4):461-8. PubMed ID: 18360692
[TBL] [Abstract][Full Text] [Related]
16. SLPI and elafin: multifunctional antiproteases of the WFDC family.
Scott A; Weldon S; Taggart CC
Biochem Soc Trans; 2011 Oct; 39(5):1437-40. PubMed ID: 21936829
[TBL] [Abstract][Full Text] [Related]
17. Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.
Nyström M; Bergenfeldt M; Ljungcrantz I; Lindeheim A; Ohlsson K
Mediators Inflamm; 1999; 8(3):147-51. PubMed ID: 10704052
[TBL] [Abstract][Full Text] [Related]
18. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
[TBL] [Abstract][Full Text] [Related]
19. The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation.
Westin U; Nyström M; Ljungcrantz I; Eriksson B; Ohlsson K
Mediators Inflamm; 2002 Feb; 11(1):7-12. PubMed ID: 11926597
[TBL] [Abstract][Full Text] [Related]
20. WAP domain proteins as modulators of mucosal immunity.
Wilkinson TS; Roghanian A; Simpson AJ; Sallenave JM
Biochem Soc Trans; 2011 Oct; 39(5):1409-15. PubMed ID: 21936824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
